• Home
  • News
  • Investor relations
  • About us
  • Products
  • Projects
  • Media
  • Contact
Skip to content
logo SDS Optics
Polski English
  • About us
    ▾
    Our team
    Working together to create innovative solutions and bring them to patients and doctors.
    Our vision
    Our team consists of renown experts in biology, medicine, advanced technologies, chemistry and related sciences.
    Who we are
    At SDSOPTIC we strive to make difference in the world. We are connecting vast medical knowledge with technical skills to create medical devices that can revolutionise healthcare in the world.
  • Products
    ▾
    Medical devices
    SDS Optic invented and developed inPROBE - cancer diagnosis device designed to reduce time of medical diagnosis, increase precision and effects of advanced cancer treatments and most importantly – help medical professionals to save lives of millions of patients worldwide.
    Optoelectronics
    SDS OPTIC specializes in modeling and designing high-quality package components, such as ferrules, housings, and other devices with flat and conical surface areas. We employ highly accurate assembling procedures that allow us to compose hermetic patch cords, pigtails, connectors and windows.
    Biotech r&d
    Research and development is the lifeblood of the biopharma industry and the ultimate source of the economic value it creates. R&D allows companies to generate new products that will eventually lead to growth and save lives.
  • News
  • Projects
    ▾
    NCBiR Bridge Alfa
    The funds will be used to purchase the highest quality equipment for the laboratory. The company plans to complete calibration and clinical trials in 2021
    PARP – Go to Brand
    SDS Optic was granted from PARP Go to Brand programme for inPROBE promotion actions on foreign markets
    NCBiR Strategmed
    The National Centre for Research and Development co-financed the project under the STRATEGMED and BRIDGE ALFA programme
    NCBiR Patent Plus
    The development of innovative technology for the production of laser microsomes is possible thanks to the significant support of SDS Optic from public funds, programme Patent Plus
    Horizon 2020 SME Instrument
    SDS Optic was granted €3.985.000 from the SME Instrument (Horizon 2020) programme to develop a revolutionary optical device OmiProbe
  • Investor Relations
    ▾
    Awards
    Business awards and nominations are a well-established part of our business life. Let's see competitions we've been awarded and nominated
    Investors Contact
    If you are interesting contact with us regarding investor relations, please contact person below or fill contact form
    Ownership structure
    Ownership structure is presented by shareholders and by number of shares
    Media about SDS Optic
    Here you can find latest publications about SDS Optic
    Leadership
    Learn more about our structure, management team and supervisory board
  • Media
    ▾
    In the news
    You can find information about us in international news, breaking news, tv programmes and articles
    Media relations
    Learn more about SDS Optic progress, and explore our recent announcements and resources.
  • Contact
    ▾
  • facebook
  • facebook
  • facebook
  • youtube
  • instagram

In the news

SDS Optic is committed to providing the media with timely and accurate information. This section offers key resources for journalists, editors and other media professionals. Here you can read more about progress, and explore our recent announcements and resources.

Lubelscy naukowcy: Dzięki tej metodzie szybciej wykryjemy raka piersi
RMF FM

Unikalny projekt naukowców z Lublina. Dzięki niemu szybciej można wykryć raka piersi
ZDROWIEGAZETA.PL

Polski projekt przyszłością diagnostyki onkologicznej
PULS MEDYCYNY

Szybki test nowotworowy
PANORAMA TVP PL

Rewolucja w diagnostyce raka piersi – mikrosonda InProbe
ONKONET

Naukowcy z Lublina opracowali rewolucyjną metodę wykrywania raka piersi
FAKT

Rewolucja w diagnostyce raka nadciąga z Lublina
RADIO LUBLIN

Lubelscy naukowcy opracowali szybszą metodę wykrywania raka piersi
ONET

Polski projekt przyszłością diagnostyki onkologicznej
INŻYNIER MEDYCZNY

Lubelski wykrywacz raka
NOWY TYDZIEŃ

To urządzenie sprawdzi w kwadrans, czy nowotwór jest złośliwy
RYNEK ZDROWIA

SDS Optic zdobywcą nagrody Wschodzące Technologie
PULS BIZNESU



Get in touch
Tel +48 81 501 94 63
email: office@sdsoptic.pl
www.sdsoptic.pl
Social media
facebook facebook facebook youtube instagram

Privacy policy
Adress
SDS Optic Inc
Centrum ECOTECH-COMPLEX, Block A
ul. Głęboka 39
20-612 Lublin
Poland
visit inPROBE website
inprobe com
Ta strona korzysta z ciasteczek aby świadczyć usługi na najwyższym poziomie. Dalsze korzystanie ze strony oznacza, że zgadzasz się na ich użycie.ZgodaPolityka prywatności